|
1
|
Cassileth B, Yeung KS and Gubili J: Herbs
and other botanicals in cancer patient care. Curr Treat Options
Oncol. 9:109–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schmidt BM, Ribnicky DM, Lipsky PE and
Raskin I: Revisiting the ancient concept of botanical therapeutics.
Nat Chem Biol. 3:360–366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang L, Zhou GB, Liu P, Song JH, Liang Y,
Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ and Chen Z:
Dissection of mechanisms of Chinese medicinal formula
Realgar-Indigo naturalis as an effective treatment for
promyelocytic leukemia. Proc Natl Acad Sci USA. 105:4826–4831.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
HemaIswarya S and Doble M: Potential
synergism of natural products in the treatment of cancer. Phytother
Res. 20:239–249. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Imai M, Kikuchi H, Denda T, Ohyama K,
Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a
human colon cancer derived cell line, COLO 201: a potential natural
anti-cancer substance. Cancer Lett. 276:74–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Imai M, Kikuchi H, Yuan B, Aihara Y,
Mizokuchi A, Ohyama K, Hirobe C and Toyoda H: Enhanced growth
inhibitory effect of 5-fluorouracil in combination with Vitex
agnus-castus fruits extract against a human colon
adenocarcinoma cell line, COLO 201. J Chin Clin Med. 6:14–19.
2011.
|
|
7
|
Imai M, Yuan B, Kikuchi H, Saito M, Ohyama
K, Hirobe C, Oshima T, Hosoya T, Morita H and Toyoda H: Growth
inhibition of a human colon carcinoma cell, COLO 201, by a natural
product, Vitex agnus-castus fruits extract, in vivo and in
vitro. Adv Biol Chem. 2:20–28. 2012. View Article : Google Scholar
|
|
8
|
Yuan B, Imai M, Kikuchi H, Fukushima S,
Hazama S, Akaike T, Yoshino Y, Ohyama K, Hu X, Pei X and Toyoda H:
Cytocidal effects of polyphenolic compounds, alone or in
combination with, anticancer drugs against cancer cells: potential
future application of the combinatory therapy. Apoptosis and
Medicine. Ntuli TM: InTech; Croatia: pp. 155–174. 2012
|
|
9
|
Ohyama K, Akaike T, Hirobe C and Yamakawa
T: Cytotoxicity and apoptotic inducibility of Vitex
agnus-castus fruit extract in cultured human normal and cancer
cells and effect on growth. Biol Pharm Bull. 26:10–18.
2003.PubMed/NCBI
|
|
10
|
Ohyama K, Akaike T, Imai M, Toyoda H,
Hirobe C and Bessho T: Human gastric signet ring carcinoma
(KATO-III) cell apoptosis induced by Vitex agnus-castus
fruit extract through intracellular oxidative stress. Int J Biochem
Cell Biol. 37:1496–1510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma L, Lin S, Chen R and Wang X: Treatment
of moderate to severe premenstrual syndrome with Vitex agnus castus
(BNO 1095) in Chinese women. Gynecol Endocrinol. 26:612–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schellenberg R: Treatment for the
premenstrual syndrome with agnuscastus fruit extract: prospective,
randomised, placebo controlled study. BMJ. 322:134–137. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kikuchi H, Yuan B, Nishimura Y, Imai M,
Furutani R, Kamoi S, Seno M, Fukushima S, Hazama S, Hirobe C,
Ohyama K, Hu XM, Takagi N, Hirano T and Toyoda H: Cytotoxicity of
Vitex agnus-castus fruit extract and its major component,
casticin, correlates with differentiation status in leukemia cell
lines. Int J Oncol. 43:1976–1984. 2013.
|
|
14
|
Kikuchi H, Yuan B, Yuhara E, Takagi N and
Toyoda H: Involvement of histone H3 phosphorylation through p38
MAPK pathway activation in casticin-induced cytocidal effects
against the human promyelocytic cell line HL-60. Int J Oncol.
43:2046–2056. 2013.
|
|
15
|
Schumacker PT: Reactive oxygen species in
cancer cells: live by the sword, die by the sword. Cancer Cell.
10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: a radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J and Yi J: Cancer cell killing via
ROS: to increase or decrease, that is the question. Cancer Biol
Ther. 7:1875–1884. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan B, Yoshino Y, Kaise T and Toyoda H:
Application of arsenic trioxide therapy for patients with leukemia.
Biological Chemistry of Arsenic, Antimony and Bismuth. Sun H: John
Wiley and Sons, Ltd; Chichester: pp. 263–292. 2011
|
|
19
|
Dong JM, Zhao SG, Huang GY and Liu Q:
NADPH oxidase-mediated generation of reactive oxygen species is
critically required for survival of undifferentiated human
promyelocytic leukemia cell line HL-60. Free Radic Res. 38:629–637.
2004. View Article : Google Scholar
|
|
20
|
Yuan B, Ohyama K, Bessho T, Uchide N and
Toyoda H: Imbalance between ROS production and elimination results
in apoptosis induction in primary smooth chorion trophoblast cells
prepared from human fetal membrane tissues. Life Sci. 82:623–630.
2008. View Article : Google Scholar
|
|
21
|
Kon A, Yuan B, Hanazawa T, Kikuchi H, Sato
M, Furutani R, Takagi N and Toyoda H: Contribution of membrane
progesterone receptor α to the induction of progesterone-mediated
apoptosis associated with mitochondrial membrane disruption and
caspase cascade activation in Jurkat cell lines. Oncol Rep.
30:1965–1970. 2013.
|
|
22
|
Yuan B, Ohyama K, Takeichi M and Toyoda H:
Direct contribution of inducible nitric oxide synthase expression
to apoptosis induction in primary smooth chorion trophoblast cells
of human fetal membrane tissues. Int J Biochem Cell Biol.
41:1062–1069. 2009. View Article : Google Scholar
|
|
23
|
Yuan B, Ohyama K, Bessho T and Toyoda H:
Contribution of inducible nitric oxide synthase and
cyclooxygenase-2 to apoptosis induction in smooth chorion
trophoblast cells of human fetal membrane tissues. Biochem Biophys
Res Commun. 341:822–827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perner A, Andresen L, Pedersen G and
Rask-Madsen J: Superoxide production and expression of NAD(P)H
oxidases by transformed and primary human colonic epithelial cells.
Gut. 52:231–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reddy L, Odhav B and Bhoola KD: Natural
products for cancer prevention: a global perspective. Pharmacol
Ther. 99:1–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu XM, Yuan B, Tanaka S, Zhou Q, Onda K,
Toyoda H and Hirano T: Involvement of oxidative stress associated
with glutathione depletion and p38 mitogen-activated protein kinase
activation in arsenic disulfide-induced differentiation in HL-60
cells. Leuk Lymphoma. 55:392–404. 2014. View Article : Google Scholar
|
|
27
|
Frantz B, Klatt T, Pang M, Parsons J,
Rolando A, Williams H, Tocci MJ, O’Keefe SJ and O’Neill EA: The
activation state of p38 mitogen-activated protein kinase determines
the efficiency of ATP competition for pyridinylimidazole inhibitor
binding. Biochemistry. 37:13846–13853. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Young PR, McLaughlin MM, Kumar S, Kassis
S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr
SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL and Lee
JC: Pyridinyl imidazole inhibitors of p38 mitogen-activated protein
kinase bind in the ATP site. J Biol Chem. 272:12116–12121. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Keyse SM and Tyrrell RM: Hemeoxygenase is
the major 32-kDa stress protein induced in human skin fibroblasts
by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl
Acad Sci USA. 86:99–103. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lau AT, Wang Y and Chiu JF: Reactive
oxygen species: current knowledge and applications in cancer
research and therapeutic. J Cell Biochem. 104:657–667. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kobayakawa J, Sato-Nishimori F, Moriyasu M
and Matsukawa Y: G2-M arrest and antimitotic activity mediated by
casticin, a flavonoid isolated from Viticis Fructus (Vitex
rotundifolia Linne fil.). Cancer Lett. 208:59–64. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Chen P, Sinogeeva N, Gorospe M,
Wersto RP, Chrest FJ, Barnes J and Liu Y: Arsenic trioxide promotes
histone H3 phosphoacetylation at the chromatin of CASPASE-10 in
acute promyelocytic leukemia cells. J Biol Chem. 277:49504–49510.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Waring P, Khan T and Sjaarda A: Apoptosis
induced by gliotoxin is preceded by phosphorylation of histone H3
and enhanced sensitivity of chromatin to nuclease digestion. J Biol
Chem. 272:17929–17936. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Clayton AL and Mahadevan LC: MAP
kinase-mediated phosphoacetylation of histone H3 and inducible gene
regulation. FEBS Lett. 546:51–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee YJ and Shukla SD: Histone H3
phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK
in rat hepatocytes exposed to ethanol and acetaldehyde. Eur J
Pharmacol. 573:29–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kuruüzüm-Uz A, Güvenalp Z, Ströch K,
Demirezer LO and Zeeck A: Antioxidant potency of flavonoids from
Vitex agnus-castus L. growing in Turkey. FABAD J Pharm Sci.
33:11–16. 2008.
|
|
37
|
Jozkowicz A, Was H and Dulak J: Heme
oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal.
9:2099–2117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hill M, Pereira V, Chauveau C, Zagani R,
Remy S, Tesson L, Mazal D, Ubillos L, Brion R, Asghar K, Mashreghi
MF, Kotsch K, Moffett J, Doebis C, Seifert M, Boczkowski J, Osinaga
E and Anegon I: Heme oxygenase-1 inhibits rat and human breast
cancer cell proliferation: mutual cross inhibition with indoleamine
2,3-dioxygenase. FASEB J. 19:1957–1968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sánchez Y, Amrán D, Fernández C, de Blas E
and Aller P: Genistein selectively potentiates arsenic
trioxide-induced apoptosis in human leukemia cells via reactive
oxygen species generation and activation of reactive oxygen
species-inducible protein kinases (p38-MAPK, AMPK). Int J Cancer.
123:1205–1214. 2008.
|
